Updated:
Rosalind Franklin University of Medicine and Science Endowment
Rosalind Franklin University of Medicine and Science, founded in 1912, operates as a private graduate school from its main campus in North Chicago, Illinois.
Rosalind Franklin University of Medicine and Science Endowment
Rosalind Franklin University of Medicine and Science, founded in 1912, operates as a private graduate school from its main campus in North Chicago, Illinois. The endowment receives permanently restricted donations and invests them to produce yearly distributions for the university's mission. President and CEO Wendy Rheault oversees the institution. The endowment pursues a multi-asset strategy that spans buyout, distressed debt, venture capital, mezzanine, and special-situations investments. Its stage coverage runs from early-stage seed and startup rounds through expansion and late-stage vehicles. Known co-investment relationships include the Michael Reese Research and Education Foundation, a major grantor for health equity research, and DePaul University, a partner in a joint pilot grant program for AI-driven biomedical research. The fund's geographic focus centers on North America. The portfolio's deployment is housed within a broader asset base that includes the Innovation and Research Park and the Helix 51 Biomedical Incubator, both on the North Chicago campus. The university draws expertise from an External Advisory Council that includes Paul Weiss, a managing director at Venture Investors, and Karen Heidelberger, a partner at Deerfield Management. Trustee-level relationships connect the endowment to J.P. Morgan Private Bank, the Dr. Scholl Foundation, and the Healthcare Foundation of Northern Lake County. In May 2024, no single dated operational event beyond its ongoing investment activity is verifiable from public disclosures. A structural differentiator for the fund is its integration with an on-campus incubator and research park, creating a sourcing channel adjacent to academic innovation. Investment decisions are guided by a trustee and advisory network drawn from private equity firms, private banking, and health-focused foundations, giving the endowment access to deal flow uncommon for an institution of its size.
General information
Firm type
Endowment / Foundation
Year founded
1912
Location
Region
North America
Country
United States
City
North Chicago
Corporate office
3333 Green Bay Road, North Chicago, IL 60064, United States
Principals
Wendy Rheault
President and CEO
Sector focus
Frequently asked questions
Who runs investment decisions at the Rosalind Franklin University endowment?
President and CEO Wendy Rheault oversees the university and its endowment. The institution draws on an External Advisory Council that includes investment professionals from Venture Investors and Deerfield Management, as well as trustees from J.P. Morgan Private Bank and the Dr. Scholl Foundation. Day-to-day investment management responsibilities are not publicly detailed.
Does the endowment participate in fund commitments or only direct deals?
The endowment's strategy documentation lists buyout, distressed debt, early-stage venture, expansion, mezzanine, and special situations. Known co-investor relationships exist with the Michael Reese Research and Education Foundation, suggesting direct or club-style participation. The fund's limited public disclosures do not specify whether it also commits to third-party funds.
What investment stages does the RFU endowment target?
The portfolio spans seed, start-up, expansion, and late-stage investments. This full-spectrum approach covers both early-stage venture and more mature corporate transactions, alongside distressed and special-situations opportunities when they arise.
How is the endowment related to the Helix 51 Biomedical Incubator?
Helix 51 is a commercial biomedical incubator located on the university's North Chicago campus and is part of the institution's broader asset base. Its proximity creates a potential pipeline of early-stage life-science companies that align with the endowment's healthcare and AI focus, although any formal investment mandate tied to the incubator is not publicly disclosed.
Where does the endowment's underlying capital come from?
The corpus is built from permanently restricted donations to the university, which are invested to generate annual distributions supporting graduate health-science programs. The specific wealth origin of major donors is not publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: